Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Return on Sales (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Return on Sales for 5 consecutive years, with 0.29% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 258.0% to 0.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29%, a 258.0% increase, with the full-year FY2011 number at 62.85%, down 3857.0% from a year prior.
  • Return on Sales was 0.29% for Q4 2025 at Lexicon Pharmaceuticals, down from 0.17% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.13% in Q2 2025 to a low of 36.4% in Q3 2024.